Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge): A Pragmatic Cluster Randomized Control Trial

NCT04000503 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT04000503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04000503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge): A Pragmatic Cluster Randomized Control Trial
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2019
Completion date
October 31, 2022
Enrollment
2,019 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, human papillomavirus 16, human papillomavirus 18, papillomavirus infections, pre-cancerous dysplasia